Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer
August 08, 2022 04:07 ET
|
Helsinn Healthcare S.A.
Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer Lugano, Switzerland, August 8, 2022 - Helsinn Group (“Helsinn”), a fully integrated, global...